Key result
Incomplete revascularization in patients undergoing TAVR was associated with increased mortality compared to reasonable incomplete revascularization.
Why the study?
Does incomplete revascularization increase mortality compared to reasonable incomplete revascularization or no CAD in patients undergoing transcatheter aortic valve replacement?
Meta-Analysis (n=3,107)
Does incomplete revascularization increase mortality compared to reasonable incomplete revascularization or no CAD in patients undergoing transcatheter aortic valve replacement?
In patients undergoing transcatheter aortic valve replacement, incomplete coronary revascularization is associated with significantly higher mortality compared to reasonable incomplete revascularization or having no CAD.
Answers are grounded in this paper and cite their sources.
Incomplete revascularization may signal higher TAVR mortality risk; extends observational data but leaves causality and practice change open.
Background— Coronary artery disease (CAD) is highly prevalent in patients undergoing transcatheter aortic valve replacement. In the overall CAD population, complete revascularization or reasonable incomplete revascularization (ICR) is associated with improved outcomes; whether the same applies for the transcatheter aortic valve replacement population is still a matter of debate. Methods and Results— We conducted a systematic review and meta-analysis of studies that examined the prognostic effect of revascularization completeness in patients undergoing transcatheter aortic valve replacement using the residual SYNTAX score (Synergy Between PCI With Taxus and Cardiac Surgery) to separate between reasonable ICR and ICR (using the individual threshold used by each study). Six studies with a total of 3107 patients were included. The duration of follow-up ranged from 0.7 to 3 years. Overall, ICR was associated with an increased risk for mortality. This was true when comparing ICR patients to those with no CAD (odds ratio, 1.85; 95% confidence interval, 1.42–2.40; P <0.01), to those with reasonable ICR (odds ratio, 1.69; 95% confidence interval, 1.26–2.28; P <0.001), or to both groups combined (odds ratio, 1.71; 95% confidence interval, 1.36–2.16; P <0.001). On the contrary, patients in the reasonable ICR category did not show an increased risk for mortality when compared with those with no CAD (odds ratio, 1.11; 95% confidence interval, 0.89–1.39; P =0.33). Conclusions— Our results suggest that for patients with CAD undergoing transcatheter aortic valve replacement, a residual SYNTAX score–guided revascularization strategy may carry significant benefits in terms of mortality. Adequate revascularization may offer a unique and valuable opportunity to improve the prognosis of these patients.
No takes yet. Share an insight, caveat, or question.
Witberg et al. (2018) conducted a meta-analysis in Coronary artery disease undergoing transcatheter aortic valve replacement (n=3,107). Incomplete revascularization (ICR) vs. Reasonable ICR or no CAD was evaluated on Mortality (OR 1.69, 95% CI 1.26-2.28, p=<0.001). Incomplete revascularization in patients undergoing TAVR was associated with increased mortality compared to reasonable incomplete revascularization.
Synapse has enriched 10 related papers. Consider them for comparative context: